title: Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
authors.affiliation: Laboratory of Physiologic Studies, National Institute on Alcohol Abuse & Alcoholism, National Institutes of Health, Bethesda, Md 20892-8115, USA.
authors.forename: Sándor
authors.initials: S
authors.lastname: Bátkai
authors.forename: Pál
authors.initials: P
authors.lastname: Pacher
authors.forename: Douglas
authors.initials: D
authors.lastname: Osei-Hyiaman
authors.forename: Svetlana
authors.initials: S
authors.lastname: Radaeva
authors.forename: Jie
authors.initials: J
authors.lastname: Liu
authors.forename: Judith
authors.initials: J
authors.lastname: Harvey-White
authors.forename: László
authors.initials: L
authors.lastname: Offertáler
authors.forename: Ken
authors.initials: K
authors.lastname: Mackie
authors.forename: M Audrey
authors.initials: MA
authors.lastname: Rudd
authors.forename: Richard D
authors.initials: RD
authors.lastname: Bukoski
authors.forename: George
authors.initials: G
authors.lastname: Kunos
mesh_terms: D000581:Amidohydrolases / Q000037:antagonists & inhibitors; D000804:Angiotensin II / Q000633:toxicity; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D001892:Camphanes / Q000494:pharmacology; D002219:Carbamates / Q000494:pharmacology; D013759:Dronabinol / Q000031:analogs & derivatives* / Q000494:pharmacology; D063388:Endocannabinoids; D004730:Endothelium, Vascular / Q000378:metabolism; D006973:Hypertension / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology*; D008297:Male; D008955:Models, Cardiovascular; D009200:Myocardial Contraction / Q000187:drug effects* / Q000502:physiology; D009206:Myocardium / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D020303:Rats, Inbred Dahl; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D017207:Rats, Sprague-Dawley; D043884:Receptor, Cannabinoid, CB1 / Q000187:drug effects* / Q000502:physiology; D000077285:Rimonabant; D015854:Up-Regulation; D014655:Vascular Resistance / Q000187:drug effects* / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology; D000099252:Fatty Acid Amide Hydrolases
chemical_list: D000581:Amidohydrolases; D000804:Angiotensin II; D001095:Arachidonic Acids; D001549:Benzamides; D001593:Benzyl Compounds; D001892:Camphanes; D002219:Carbamates; D013759:Dronabinol; D063388:Endocannabinoids; D010880:Piperidines; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant; D000099252:Fatty Acid Amide Hydrolases; C474343:OMDM-2 cpd; C110630:SR 144528; C500528:cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester; C103505:AM 251; C062018:HU 211; C078814:anandamide; C107594:N-(4-hydroxyphenyl)arachidonylamide